<?xml version="1.0"?>
<tei xml:space="preserve">
	<teiHeader>
		<fileDesc xml:id="0"/>
	</teiHeader>
	<text xml:lang="en">
			<head>1. INTRODUCTION<lb/></head>

			<p>Most of the substituted-4-thiazolidinones exhibit a wide range<lb/> of pharmacological, medicinal and biological properties as anti-<lb/>bacterial <ref type="biblio">[1, 2]</ref>, antifungal <ref type="biblio">[3]</ref>, antitubercular <ref type="biblio">[4]</ref>, anticancer <ref type="biblio">[5]</ref>,<lb/> antiinflammatory <ref type="biblio">[6]</ref>, antianalgesic <ref type="biblio">[7]</ref>, anticonvulsant <ref type="biblio">[8]</ref>, antide-<lb/>pressant <ref type="biblio">[9]</ref>, antiviral /anti HIV <ref type="biblio">[10]</ref>, antidiaberic <ref type="biblio">[11]</ref>, a muscarinic<lb/> receptor1-agonist <ref type="biblio">[12]</ref>, an FSH receptor agonist <ref type="biblio">[13]</ref>, trypanocidal<lb/> (anti-epimastigote) <ref type="biblio">[14]</ref> and antiarrhythmic activity <ref type="biblio">[15, 16]</ref>.<lb/></p>

			<p>Introduction of fluorine atoms to heterocyclic nitrogen systems<lb/> often improves their physical with chemical advantages and<lb/> enhances their biological activity <ref type="biblio">[17-20]</ref>. Based on these obser-<lb/>vations, the present work describes the development of new<lb/> fluorine compound substituted rhodanine derivatives which may<lb/> enhance the biological effects, as cellobiase produced by fungi as<lb/> well as CDK2 inhibitors for tumor cell (DNA damage).<lb/></p>

			<p>The structure-activity relationship has been discussed and their<lb/> binding conformation is further clarified by molecular modification<lb/> studies.<lb/></p>

			<head>2. MATERIALS AND METHODS<lb/></head>

			<p>All the melting points were determined on Stuart scientific<lb/> SMP30 (Bibby, UK) melting point apparatus and reported as<lb/> uncorrected. The FT-IR spectra were recorded on a Perkin-Elmer<lb/> *Address correspondence to this author at the Department of Chemistry, Faculty of<lb/> Science, King Abdul Aziz University, P.O. Box. 42805, Jeddah 21551, Saudi Arabia;<lb/> Tel: +966531097330; E-mail: ro-0s@hotmail.com<lb/> spectrum 100 spectrometer in ATR. 1 H, 13 C and 19 F NMR spectra<lb/> were recorded on a Brucker advance DPX NMR spectrometer (400<lb/> and 100 MHz, respectively), by using DMSO-d 6 as a solvent<lb/> (chemical shift in δ, ppm), and TMS as an internal standard. Ele-<lb/>mental analysis was conducted by a 2400 Perkin Elmer series 2<lb/> analyzer. Mass spectra were determined by using quadruple MS<lb/> (Electronic ionization mod E1 mode with source temperature:<lb/> 200ºC) at 70 eV. All the reactions were monitored by TLC, using<lb/> silica gel coated Al plates with a fluorescent indicator F254<lb/> (Merck).<lb/> </p>
				
			<p>19 F NMR spectra of all the compounds 2-16 showed resonated<lb/> signals as d,d at -119.75 and -123.16 ppm.<lb/></p>

			<head>3. RESULTS AND DISCUSSION<lb/> </head>
				
			<head>3.1. Chemistry<lb/></head>

			<p>A literature survey reported a new fluorine compound substi-<lb/>tuted for rhodanine at positions SH, NH 3 , and active CH 2 positions<lb/> <ref type="biblio">[21]</ref> and is used for detecting Tau pathology in Alzheimer&apos;s Brains<lb/> <ref type="biblio">[22]</ref> as well as inhibitors of JSP-1 <ref type="biblio">[23]</ref>.<lb/></p>

			<p>In view of these results, the aim of this work was to search for<lb/> new fluorine compounds derived from rhodanine drug with a hope<lb/> to enhance their biological activity.<lb/></p>

			<p>Thus, hydroxyl methylation and/ or Mannich bases of 5-(4-<lb/>fluorobenzylidene)-2-thioxothiazolidin-4-one (2) <ref type="biblio">[24]</ref> via refluxing<lb/> with HCHO-MeOH and /or HCHO-MeOH with secondary amines<lb/> afforded N 3 -substituted rhodanine 3-5 (Scheme <ref type="figure">1</ref>).<lb/></p>

			<p>A simple nucleophilic attack of primary aliphatic/aromatic<lb/> amines to SH group at position-2 of rhodanine by refluxing with<lb/> ethanolamine, 4-fluoroaniline and sulfanilamide (1:1 by mol) in<lb/> EtOH, furnished 2-substituted amino-5-(4&apos;-fluorobenzylidene)-4-<lb/>thiazolidinones (6-8) (Scheme <ref type="figure">2</ref>).<lb/></p>

			<p>Also, the treatment of compound 2 with POCl 3 under fusion<lb/> condition yielded 4-chloro-5-(4-fluorobenzylidene)thiazol-2(5H)-<lb/>thione (9). Chlorine atom at 4-position of rhodanine 9 was removed<lb/> by treatment with primary amines. Thus, compound 9 upon attack<lb/> by primary amines such as 4-fluoroaniline, hydrazine hydrate and<lb/> /or 4-chlorophenyl-hydrazine under refluxing with DMF produced<lb/> 5-(4-fluorobenzylidene)-4-[(4-fluorophenyl) amino]thiazol-2(5H)-<lb/>thione (10); 3-(4-fluorophenyl)-1,3-dihydro-pyrazolo[3,4-d]thiazol-<lb/>5-thione (11), and / or 2-(4-chlorophenyl)-3-(4-fluorophenyl)-1,2-<lb/>dihydropyrazolo[3,4-d]thiazol-5-thione (12) (Scheme <ref type="figure">3</ref>).<lb/></p>

			<p>Formation of 4 and 5 from 2 is shown in Fig. <ref type="figure">(1)</ref>.<lb/> </p>
				
			<figure>S<lb/> NH<lb/> O<lb/> S<lb/> O<lb/> F<lb/> +<lb/> S<lb/> NH<lb/> O<lb/> S<lb/> F<lb/> 1<lb/> 2<lb/> EtOH/ pipdn.<lb/> ! 6-8 h<lb/> S<lb/> N<lb/> O<lb/> S<lb/> F<lb/> 3<lb/> OH<lb/> HCHO/ MeOH<lb/> ! 2 h<lb/> S<lb/> N<lb/> O<lb/> S<lb/> F<lb/> 4<lb/> S<lb/> N<lb/> O<lb/> S<lb/> F<lb/> 5<lb/> HCHO/ MeOH<lb/> ! 2 h<lb/> HCHO/ MeOH<lb/> ! 2 h<lb/> HN<lb/> HN<lb/> O<lb/> N<lb/> O<lb/> N<lb/> Scheme 1. Formation of compounds 3-5 from 2.<lb/></figure>
				
			<figure>S<lb/> N !-<lb/>O<lb/> S<lb/> F 2<lb/> O<lb/> H<lb/> H<lb/> +<lb/> H d+<lb/> !+<lb/> !-<lb/>S<lb/> N<lb/> O<lb/> S<lb/> F<lb/> O<lb/> Addition<lb/> reaction<lb/> N<lb/> H<lb/> H ! -<lb/>!+<lb/> !+<lb/> ! -<lb/>-H 2 O<lb/> S<lb/> N<lb/> O<lb/> S<lb/> F<lb/> 4 or 5<lb/> N<lb/> X<lb/> X<lb/> X: 4= CH 2 , 5= O<lb/> Fig. (1). Formation of 4 and 5 from 2.<lb/> </figure>
				
			<figure>S<lb/> NH<lb/> O<lb/> S<lb/> F<lb/> 2<lb/> S<lb/> N<lb/> O<lb/> F<lb/> 6<lb/> S<lb/> N<lb/> O<lb/> F<lb/> 8<lb/> S<lb/> N<lb/> O<lb/> F<lb/> 7<lb/> N<lb/> H<lb/> OH<lb/> NH<lb/> F<lb/> NH<lb/> SO 2 NH 2<lb/> H 2 N<lb/> OH<lb/> EtOH/ ! 6 h<lb/> -H 2 S<lb/> EtOH/ ! 6 h<lb/> -H 2 S<lb/> EtOH/ ! 6 h<lb/> -H 2 S<lb/> H 2 N<lb/> SO 2 NH 2<lb/> NH 2<lb/> F<lb/> Scheme 2. Formation of compounds 6 and 7 from 2.<lb/> </figure>
			
			<figure>S<lb/> NH<lb/> O<lb/> S<lb/> F<lb/> 2<lb/> S<lb/> N<lb/> HO<lb/> S<lb/> F<lb/> S<lb/> N<lb/> Cl<lb/> S<lb/> F<lb/> 9<lb/> POCl 3<lb/> ! 1 h<lb/> S<lb/> N<lb/> S<lb/> F<lb/> 12<lb/> S<lb/> N<lb/> H<lb/> N<lb/> S<lb/> F<lb/> 10<lb/> S<lb/> N<lb/> S<lb/> F<lb/> 11<lb/> F<lb/> N<lb/> HN<lb/> Cl<lb/> N<lb/> HN<lb/> NH 2<lb/> NHNH 2<lb/> Cl<lb/> F<lb/> DMF, ! 1 h<lb/> (1:1)<lb/> -HCl<lb/> NH 2 NH 2 • H 2 O<lb/> DMF, ! 6 h<lb/> (1:1)<lb/> -HCl<lb/> DMF, ! 6 h<lb/> (1:1)<lb/> -HCl<lb/> Scheme 3. Formation of compounds 9-12 from 2.<lb/></figure>

			<p>The formation of compound 11 is shown in Fig. <ref type="figure">(2)</ref>.<lb/></p>

			<p>Alkylation of compound 2 by refluxing with monochloroacetic<lb/> acid in DMF yielded 2-[(5-(4-fluorobenzylidene)-4-oxo-4,<lb/> 5-dihydrothiazol-2-yl)thio] acetic acid (13), which on decarboxyla-<lb/>tion via warming with aqueous K 2 CO 3 gave 5-(4-fluorobenzyli-<lb/>dene)-2-(methylthio) thiazol-4(5H)-one (14) (Scheme <ref type="figure">4</ref>).<lb/></p>

			<p>The structural formula of new systems was obtained from the<lb/> correct elemental analysis and spectral data.<lb/></p>

			<p>FT-IR absorption spectra of compounds 3-5 showed the absor-<lb/>ption bands at ῡ 2980 &amp; 2888 cm -1 , attributed to endo CH= and exo<lb/> CH 2 with lack of NH group, and with the presence of ῡ at 1700,<lb/> 1610, 1240 and 1180 cm -1 due to C=O, C=C, C-F, and C=S respec-<lb/>tively. Also, FT-IR spectra of compounds 6-8 recorded ῡ at 3180-<lb/>3150 cm -1 for bonded NH which lacks the SH groups. Moreover,<lb/> FT-IR spectrum of compound 9 indicates a lack of C=O with the<lb/> presence of ῡ at 700 cm -1 for C-Cl. Also, FT-IR spectra of both the<lb/> compounds 10 and 12 recorded ῡ at 3180, 1230 and 1188 cm -1<lb/> which were attributed to the presence of NH, C-F, and C=S with<lb/> lack of C=O, while 11 showed ῡ at 3200, 3180, 1590 and 1240 cm -1<lb/> for NH, NH 2 , C=N, C-F functional groups.<lb/></p>

			<p>It is interesting to note that 1,4-disubstitutedthiazolo[5,4-<lb/>d]pyrazole-piperazine (16) isolated from the interaction of<lb/> compound 2 with piperazine (2:1 by mole) / in refluxing EtOH gave<lb/> N 1 , N 4 -disubstituted piperazine 15 followed by hydrazinolysis in<lb/> EtOH (Scheme <ref type="figure">5</ref>).<lb/></p>

			<p>FT-IR spectra of compounds 13 and 14 showed ῡ at 2980 and<lb/> 2880 cm -1 of alkyl groups, with the presence of two ῡ at 1720, and<lb/></p>

			<figure>S<lb/> N<lb/> O<lb/> SH<lb/> F<lb/> 2<lb/> N N<lb/> H<lb/> H<lb/> H<lb/> H<lb/> S<lb/> N<lb/> O<lb/> N<lb/> H<lb/> F<lb/> NH 2<lb/> N N<lb/> H<lb/> H<lb/> H<lb/> H<lb/> S<lb/> N<lb/> N<lb/> H<lb/> F<lb/> NH 2<lb/> N<lb/> N<lb/> H<lb/> H<lb/> S<lb/> N<lb/> N<lb/> H<lb/> F<lb/> NH 2<lb/> N<lb/> N<lb/> H<lb/> H<lb/> S<lb/> N<lb/> N<lb/> H<lb/> F<lb/> NH 2<lb/> N<lb/> N<lb/> 11<lb/> Cycloaddn.<lb/> outo oxidn.<lb/> !<lb/> -H 2<lb/> !<lb/> -H 2 S<lb/> !<lb/> -H 2 O<lb/> Fig. (2). Formation of compound 11 from 2.<lb/> </figure>
				
			<figure>S<lb/> NH<lb/> O<lb/> S<lb/> F<lb/> 2<lb/> S<lb/> N<lb/> O<lb/> F<lb/> 13<lb/> S<lb/> N<lb/> O<lb/> S<lb/> F<lb/> 14<lb/> S<lb/> COOH<lb/> Cl<lb/> COOH<lb/> DMF, ! 1 h<lb/> -HCl<lb/> CH 3<lb/> aq. K 2 CO 3<lb/> ! 1 h<lb/> -CO2<lb/> Scheme 4. Formation of compounds 13 and 14 from 2.<lb/> S<lb/> NH<lb/> O<lb/> S<lb/> F<lb/> 2<lb/> HN<lb/> NH<lb/> EtOH, ! 6-8 h<lb/> -2H 2 S<lb/> S<lb/> N<lb/> O<lb/> F<lb/> 15<lb/> N<lb/> N<lb/> N<lb/> S<lb/> O<lb/> F<lb/> NH 2 NH 2 • H 2 O ! 6-8 h<lb/> EtOH/ pipdn.<lb/></figure>

			<p>-H 2 O<lb/> S<lb/> N<lb/> F<lb/> 16<lb/> N<lb/> N<lb/> N<lb/> S<lb/> F<lb/> N<lb/> N<lb/> N<lb/> N<lb/> (2:1)<lb/> Scheme 5. Formation of compounds 15 and 16 from 2.<lb/> </p>f
				
			<figure>S<lb/> N<lb/> O<lb/> F<lb/> 7, M+, 315 (317, M+2, 1.5%)<lb/> NH<lb/> F<lb/> S<lb/> N<lb/> !<lb/> &quot;<lb/> #<lb/> F<lb/> NH<lb/> F<lb/> +<lb/> +<lb/> +<lb/> 95 (100)<lb/> 110 (23.8)<lb/> 84 (5.15)<lb/> #<lb/> &quot;<lb/> !<lb/> -CO 2<lb/> Fig. (3). Mass fragmentation pattern of compound 7.<lb/> </figure>
				
			<figure>S<lb/> N<lb/> H<lb/> N<lb/> S<lb/> F<lb/> 10, (M+) 332, (M+1) 333, (M+2) 334, (M+3) 335 (1.18%)<lb/> F<lb/> N<lb/> S<lb/> 71 (12)<lb/> S<lb/> F<lb/> 164 (25.10)<lb/> S<lb/> 58 (12)<lb/> NH<lb/> F<lb/> F<lb/> CH 2<lb/> F<lb/> +<lb/> +<lb/> +<lb/> 109 (80)<lb/> 95 (100)<lb/> 110 (85)<lb/> -CH 3<lb/> -NH<lb/> Fig. (4). Mass fragmentation pattern of compound 10.<lb/></figure>

			<p>1690 cm -1 attributed to C=O of acid and C=O of thiazole nucleus.<lb/> Its interesting to note that FT-IR spectrum of compound 15 showed<lb/> lack of SH and / or NH groups, with the presence ῡ at 1700, 1610<lb/> and 1230 cm -1 , for C=O, C=C, and C-F groups, respectively, while<lb/> the spectrum of 16 showed lack of C=O, C=C, NH, and SH groups.<lb/> Both the compounds 15 and 16 exhibited only ῡ at 2985, and 2880<lb/> cm -1 for stretching and ῡ at 1488, and 1440 cm -1 for bending of<lb/> CH 2 , for piperazine, respectively.<lb/></p>

			<p>1 H NMR spectra of the new compounds give more indications<lb/> about their structures.<lb/></p>

			<p>Therefore, 1 H NMR spectra of compounds 3-5 showed<lb/> resonated signals δ at 7.6 and 2.4 for the exo (C=CH-Ar) and endo<lb/> N-CH 2 , while the spectra of compound 6-8 recorded δ at 8.2 ppm<lb/> for NH bonded with aromatic protons at 7-8 ppm.<lb/></p>

			<p>Compound 6 showed δ at 7.8 and 5.1 ppm attributed to NH,<lb/> OH, and CH 2 protons. Also, 1 H NMR spectra of compounds 10-12<lb/> indicate the existence of NH protons with aryl protons at δ 8.5-8.1<lb/> and 7.6-7.4 (m &amp; m) ppm. Both the compounds 13 and 14 showed δ<lb/> at 2.5 ppm for aliphatic protons. Only 1 H NMR spectra of com-<lb/>pounds 15 and 16 exhibited resonated signals at δ 2.90⁓2.51 ppm<lb/> for N-CH 2 , and aryl-H with lack of both SH and NH protons. All<lb/> the compounds recorded δ at 7.5 and 7.4 (d,d) ppm being attributed<lb/> to CH-F protons. The interaction can occur only in &apos;&apos;Z&apos;&apos; geometry.<lb/> Thus, the exocyclic -CH=C-was deduced from recorded signals at<lb/> higher chemical shift at δ7.6 ppm <ref type="biblio">[28]</ref>.<lb/> </p>
				
			<p>Also, 13 C NMR spectra of compounds 3-5 showed resonated<lb/> signals at δ 180, 170⁓165, 146 and 142 ppm for C=S, C=O, C-F,<lb/> C=C respectively, while that of 6-8, there was lack of C=S carbons.<lb/> 13 C NMR spectra of both 10 and 12 exhibited signals at δ 180, 146,<lb/> 144, and 142-140 ppm which were attributed to C=S, C-F, C-Cl,<lb/> C=N respectively, and aryl carbons at 133-128 ppm; while the<lb/> spectra of compound 11 showed a resonated signal at 180 ppm for<lb/> C=S. Mass fragmentation pattern of some compounds showed a<lb/> molecular ion peak, which, under the fragmentation process pro-<lb/>duced the base peak m/e 95 attributed to 4-fluorophenyl ions shown<lb/> in Figs. <ref type="figure">(3-5)</ref>. The pathway fragment steps indicated the relation-<lb/>ship between the common base peak which had a significant role in<lb/> the biodynamic effects.<lb/></p>

			<p>It is interesting that 13 C NMR spectrum of compound 13,<lb/> showed lack of C-OH proton, due to the H-bonding formed as<lb/> shown in Fig. <ref type="figure">(6)</ref>.<lb/></p>

			<p>Finally, 19 F NMR spectra of all the synthesized compounds 2-<lb/>16 showed resonated signals as d,d at -119.75 and -123.16 ppm for<lb/> the fluorine bonded to the aromatic nucleus.<lb/></p>

			<head>3.2. Biological Evaluation<lb/> </head>
				
			<head>3.2.1. Antifungal Activity<lb/></head>

			<p>All the obtained compounds were evaluated as fungicidal<lb/> probes against Candida albicans and Aspergillus Fumigatus fungi<lb/> by using DMSO as the solvent (1mg/ml) and Ketoconazole as the<lb/> standard drug. The inhibition was recorded by measuring the di-<lb/>ameter inhibition zones at the end of 48 h according to the reported<lb/> method (Table <ref type="table">1</ref>) <ref type="biblio">[25]</ref>.<lb/></p>

			<figure>S<lb/> N<lb/> O<lb/> S<lb/> F<lb/> 13<lb/> O<lb/> O<lb/> H<lb/> !-<lb/>!+<lb/> Fig. (6). H-bonding in compound 13.<lb/> </figure>
				
			<figure>S<lb/> N<lb/> F<lb/> 16, (M+) 520, (M+2) 522, (M+3) 524 (15.15%)<lb/> N<lb/> N<lb/> N<lb/> S<lb/> F<lb/> N<lb/> N<lb/> N<lb/> N<lb/> HN<lb/> N<lb/> 85 (76)<lb/> F<lb/> +<lb/> 95 (100)<lb/> S<lb/> N<lb/> 96 (12.1)<lb/> S<lb/> N<lb/> F<lb/> N<lb/> N<lb/> +<lb/> S<lb/> N<lb/> N<lb/> N<lb/> +<lb/> 218 (5.16)<lb/> 124 (27.0)<lb/> F<lb/> S<lb/> N<lb/> +<lb/> 190 (8.5)<lb/> -N 2<lb/> +<lb/> Fig. (5). Mass fragmentation pattern of compound 16.<lb/></figure>

			<figure type="table">Table 1.<lb/> The biological activity as antifungal of the new fluori-<lb/>nated-substituted rhodanine.<lb/> Compd. No.<lb/> C. Albicans<lb/> (µg/ml)<lb/> A. Fumigatus<lb/> (µg/ml)<lb/> 3<lb/> 16<lb/> 14<lb/> 4<lb/> 15<lb/> 12<lb/> 5<lb/> 16<lb/> 13<lb/> 6<lb/> 14<lb/> 10<lb/> 7<lb/> 15<lb/> 11<lb/> 8<lb/> 20<lb/> 18<lb/> 9<lb/> 12<lb/> 10<lb/> 10<lb/> 19<lb/> 17<lb/> 11<lb/> 12<lb/> 11<lb/> 12<lb/> 15<lb/> 10<lb/> 13<lb/> 18<lb/> 18<lb/> 14<lb/> 19<lb/> 19<lb/> 15<lb/> 10<lb/> 8<lb/> 16<lb/> 8<lb/> 7<lb/> Ketoconazole<lb/> 18<lb/> 16<lb/></figure>

			<p>From the results, we can conclude that all the fluorinated sys-<lb/>tems exhibited an antifungal activity. Higher effects of compounds<lb/> were observed towards the two tested fungi as: 14 &gt; 13, 8 &gt; 7 &gt; 6<lb/> and 10 &gt; 12 &gt; 11 &gt; 3 &gt; 5 &gt; 4.<lb/></p>

			<p>Also, the result obtained indicated a particular activity more<lb/> than the standard drug used in the order 8 &gt; 10 &gt; 14 &gt; 5 &gt; 3, while<lb/> compounds 1,4-disubstituted piperazine 15 and 16 exhibited a lethal<lb/> activity.<lb/></p>

			<head>3.2.2. The Enzymatic Effects on Cellobiase of Some Fungi<lb/></head>

			<p>The efficiency of the synthesized fluorinated systems obtained<lb/> towards the activity of cellobiase produced enzyme as thermophilic<lb/> fungi namely, Thermomyces lanuginosus and Chaetomium Ther-<lb/>mophilum was evaluated according to the reported method <ref type="biblio">[26]</ref>. In<lb/> DMF, which was used as a solvent, the enzyme solution and the<lb/> substrate (cellobiase) was added and the solution was then dis-<lb/>solved in citrate-phosphate buffer at pH 5 and incubated at 40ºC for<lb/> 1 h. The freed reducing sugar was evaluated colorimetrically at 540<lb/> nm as an induction for the enzymatic activity <ref type="biblio">[27]</ref>.<lb/></p>

			<figure type="table">Table 2.<lb/> The efficiency of new compounds on cellobiase activity<lb/> produced by thermophilic fungi * .<lb/> Compd. No.<lb/> Amount of Glucose (mg/ml)<lb/> C. Thermophilum<lb/> T. lanuginosus<lb/> 5<lb/> 4.6<lb/> 5.2<lb/> 8<lb/> 8.0<lb/> 8.8<lb/> 10<lb/> 7.8<lb/> 8.0<lb/> 13<lb/> 6.2<lb/> 7.0<lb/> 14<lb/> 7.0<lb/> 7.7<lb/> * Blank: 0.97 and 0.80 mg/ml-without substance DMF. DMF: 0.7 and 0.72 mg/ml.<lb/></figure>

			<p>The data is recorded in Table <ref type="table">2</ref>. Only compounds 5, 8, 10, 13<lb/> and 14 showed higher activity against the two tested fungi, which<lb/> showed the activity of reducing sugar in the order 8 &gt; 10 &gt;14 &gt;13 &gt;<lb/> 5. The relationship between the structure and activity showed that<lb/> the presence of a sulfa drug, fluoroaniline, and alkylthia of 5-(4&apos;-<lb/>fluorobenzylidene) -2-thioxo-thiazol-5-one Skelton enhanced the<lb/> antifungal activity.<lb/></p>

			<head>3.2.3. CDK2 Inhibition of Tumor Cells (DNA Damage)<lb/></head>

			<p>Cyclin dependent-kinases are a family of serine/ threonine<lb/> kinases, that strongly control the mammalian cell-cycle by binding<lb/> to cyclins. Thus, CDK/ cyclin complexes are involved in the DNA<lb/> repair when they are presented in the inhibition state in response to<lb/> DNA damage <ref type="biblio">[28-31]</ref>.<lb/></p>

			<p>Also, the presence of fluorine atom in various hetero-cyclic ni-<lb/>trogen/ sulfur and oxygen systems, has a significant effect on the<lb/> modulation of electronic, lipophilic and steric parameters determing<lb/> the pharmacodynamic and pharmacokinetic properties <ref type="biblio">[32]</ref>.<lb/></p>

			<p>Thus, the new fluorine substituted rhodanines (2-16) have been<lb/> evaluated toward CDK2 in a biochemical assay. The inhibitory<lb/> concentration (IC 50 ) values were reported according to the methods<lb/> described above <ref type="biblio">[33]</ref>. Olomoucine has been used as a standard, and<lb/> the results are reported in Table <ref type="table">3</ref>. From the data obtained, we can<lb/> indicate that:<lb/> All the tested compounds showed a very significant CDK2 in-<lb/>hibitory activity. Only, compound 2 showed an Olomoucine effect,<lb/> while the other tested compounds were observed to be more potent<lb/> than the standard control. It is interesting to note that compound 10<lb/> had a higher enzymatic effect as the strong inhibitor for CDK2,<lb/> which may be used as a new inhibitor in the future.<lb/></p>

			<figure type="table">Table 3.<lb/> CDK2 inhibiting activity of fluorinated rhodanine deriva-<lb/>tives 2-16.<lb/> Compd. No.<lb/> IC50 ± SD (µM)*<lb/> 2<lb/> 5.0 ± 1.7<lb/> 4<lb/> 6.0 ± 1.8<lb/> 8<lb/> 3.7 ± 1.7<lb/> 10<lb/> 15.0 ± 2.7<lb/> 14<lb/> 12.0 ± 1.7<lb/> 15<lb/> 12.2 ± 1.5<lb/> 16<lb/> 4.1 ± 2.8<lb/> Olomoucine<lb/> 5.0 ± 1.0<lb/> *IC50 in µM/dm -1 , SD: standard deviation.<lb/></figure>

			<head>4. EXPERIMENTAL<lb/></head>

			<p>Compound 2 was obtained according to the reported method<lb/> <ref type="biblio">[24]</ref>.<lb/></p>

			<head>4.1. 5-(4-Fluorobenzylidene)-3-(hydroxymethyl)-2-thioxo thia-<lb/>zolidin-4-one (3)<lb/></head>

			<p>A solution of 2 (1.554 g, 6.5 mmol) and HCHO (0.195 g, 6.5<lb/> mmol) in MeOH (40 ml) was refluxed for 2 h. The mixture of was<lb/> cooled down at room temperature. The precipitated product was<lb/> filtered off and crystallized from dioxane to give compound 3. Or-<lb/>ange crystals, Yield 75% (25.43 g), M.p: 128-130ºC. FT-IR spec-<lb/>trum ῡ (cm -1 ): 3450-3420(broad, OH), 3060(ArH), 2944,<lb/> 2880(aliph. CH), 1716(C=O), 1616(C=C), 1594(C=C), 1229(C-F),<lb/> 1157(C=S), 889, 852, 793(subst. phenyl), 707(C-F). 1 H NMR (400<lb/> MHz, DMSO-d 6 ) δ (ppm): 7.76(s, 1H, Ar CH=C), 7.66, 7.64(d,d,<lb/> 2H, CH-F), 7.59-7.28(m, 2H, Ar), 4.59(s, OH), 2.51-2.50(s, CH 2 -<lb/>OH). 13 C NMR (100 MHz, DMSO-d 6 ) δ (ppm): 180(C=S),<lb/> 173(C=O) 167(C-S), 162(Ar CH=C), 142(C-F), 133.6-127.42(Ar<lb/> carbons), 66.45(CH 2 carbon). Calculated, C 11 H 8 NFS 2 O 2 (269), %:<lb/> C, 49.07; H, 2.97; N, 5.20; F, 7.06, S,23.79. Found, %: C, 48.77; H,<lb/> 2.66; N, 5.01; F, 6.85; S, 23.69.<lb/></p>

			<head>4.2. Mannish Bases 4 &amp; 5<lb/></head>

			<p>A mixture of compound 2 (1.554 g, 6.5 mmol), piperidine (0.55<lb/> g, 6.5 mmol) and/ or morpholine (0.57 g, 6.5 mmol), and HCHO<lb/> (0.195 g, 6.5 mmol) in MeOH (40 ml) was refluxed for 2h. The<lb/> mixture was cooled down at room temperature. The obtained pre-<lb/>cipitate was filtered off and crystallized from dioxane to give 4 and<lb/> /or 5.<lb/></p>

			<p>4: Yellow crystals, Yield 75% (1.57 g), M.p: 165-167ºC. FT-IR<lb/> spectrum ῡ (cm -1 ): 3050(Ar CH), 2939, 2862, 2798 (aliph. CH),<lb/> 1725(C=O), 1599(C=C), 1235(C-F), 1190 (C=S), 880, 853(subst.<lb/> phenyl), 723(C-F). 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 7.62(s,<lb/> Ar-CH =C),7.60, 7.54(d,d, 2H , CH-F), 7.29-7.27(m, 2H, Ar),<lb/> 2.4(N-Me) 1.62 &amp; 1.56(CH 2 of piperidine). 13 C NMR (100 MHz,<lb/> DMSO-d 6 ) δ (ppm): 180(C=S), 173(C=O), 164(C-S), 162(Ar-<lb/>CH=C), 146(C-F), 132.32-128.82(aromatic carbons), 50.55,<lb/> 49.75(N-Me &amp; CH 2 -CH 2 of piperidine). Calculated, C 16 H 17 N 2 FS 2 O<lb/> (336), %: C, 57.14; H, 5.05; N, 8.33; F, 5.65; S, 19.04. Found, %:<lb/> C, 56.88; H, 4.91; N, 8.11; F, 5.55; S, 18.85.<lb/></p>

			<p>5: Yellow crystals, Yield 78% (1.65 g), M.p: 163-165ºC. FT-IR<lb/> spectrum ῡ (cm -1 ): 2937, 2854(str. CH), 1676(C=O), 1600(C=C),<lb/> 1448, 1412(bending CH), 1389(NCSN), 1266(C-F), 831, 803(aryl<lb/> ring). 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 7.6, 7.59(d,d 2H,<lb/> Ar), 7.52, 7.26(d,d, 2H , Ar), 3.795(s, 2H, CH 2 ), 3.53, 2.46, 1.60,<lb/> 1.54(CH 2 protons). 13 C NMR (100 MHz, DMSO-d 6 ) δ (ppm):<lb/> 180.19(C=S), 174.98(C=O), 163(C-S), 162.38(Ar-CH=C), 146(C-<lb/>F), 132-116(Ar carbons), 66.27-65.42(2H, CH 2 ), 26.16-23.71(2H,<lb/> CH 2 ). Calculated, C 15 H 15 N 2 FS 2 O 2 (338), %: C, 53.25; H, 4.43; N,<lb/> 8.28; F,5.62; S, 18.93. Found, %: C, 53.01; H, 4.13; N, 8.11; F,<lb/> 5.50; S, 18.78.<lb/></p>

			<head>4.3. 5-(4-Fluorobenzylidene)-2-[(2-hydroxyethyl)amino] thia-<lb/>zole-4(5H)-one (6)<lb/></head>

			<p>An equimolar amounts of compound 2 and ethanolamine were<lb/> mixed with in ethanol (40 ml) and refluxed for 6h. The mixture was<lb/> then cooled down at room temperature. The precipitate obtained<lb/> was filtered off and crystallized from dioxane to give compound 6.<lb/> Yellow crystals, Yield 65% (1.125g), M.p: 233-235ºC. FT-IR spec-<lb/>trum ῡ (cm -1 ): 3500 (OH), 3259(NH), 3050(ArH), 2900,<lb/> 2869(aliph. CH), 1696(C=O), 1621(C=C), 1594(C=C), 1550(C=N),<lb/> 1488, 444 (bending CH 2 ), 1228(C-F), 895, 859, 790(subst. phenyl),<lb/> 751(C-F). 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 7.8(s, 1H, NH),<lb/> 7.47, 7.46(d,d, CH-F), 7.21-7.19(m, 2H, Ar), 5.1(s, 1H , OH), 3.45 ,<lb/> 2.39(CH 2 -CH 2 ). 13 C NMR (100 MHz, DMSO-d 6 ) δ (ppm):<lb/> 163.54(C=O), 162.27(Ar-CH=C), 146(C-F), 142(C=N), 32.5-<lb/>128.02(Ar carbons), 62.78, 47.48(CH 2 -CH &amp; CH 2 -N). Calculated,<lb/> C 12 H 11 N 2 FSO 2 (266), %: C, 54.13; H, 4.13; N, 10.52; F, 7.14; S,<lb/> 12.03. Found, %: C, 53.89; H, 4.11; N, 10.35; F, 7.00; S, 11.79.<lb/></p>

			<head>4.4. 5-(4-Fluorobenzylidene)-2-[(4-fluorophenyl)amino] thia-<lb/>zole-4(5H)-one (7)<lb/></head>

			<p>Compound 2 (1.554 g, 6.5 mmol) and 4-fluoroaniline (0.723 g,<lb/> 6.5 mmol) were dissolved in EtOH (30 ml) and refluxed for 6h. The<lb/> mixture was then cooled down at room temperature. The precipi-<lb/>tated product was filtered off and crystallized from ethanol to give<lb/> compound 7. Orange crystals, Yield 80% (1.64 g), M.p: 225-227ºC.<lb/> FT-IR spectrum ῡ (cm -1 ): 3150(NH), 3050(ArH), 2854(aliph. CH),<lb/> 1678(C=O), 1610(C=C), 1590(C=N), 1465, 1413(bending CH 2 ),<lb/> 1228(C-F), 891, 856, 825(substituted phenyl), 735(C-F). 1 H NMR<lb/> (400 MHz, DMSO-d 6 ) δ (ppm): 8.2 (s. 1H, NH), 7.67, 7.61(d,d, 2H,<lb/> CH-F), 7.39-7.37(m, 4H, ArH). 13 C NMR (100 MHz, DMSO-d 6 ) δ<lb/> (ppm): 170(C=O), 169(Ar-CH=C), 145(C-F), 142(C=N), 133.47-<lb/>125.79(Ar carbons). Mass spectrum, m/z (I rel , %): 315 (317, M+2,<lb/> 1.50 %), 110(23.8), 95(100), 84(5.15). Calculated, C 16 H 10 N 2 F 2 SO<lb/> (316), %: C, 60.75; H, 3.16; N, 8.86; F, 12.02; S, 10.12. Found, %:<lb/> C, 60.55; H, 3.11; N, 8.59; F, 11.83; S, 10.01.<lb/></p>

			<head>4.5. 4-[(5-(4-Fluorobenzylidene)-4-oxo-4,5-dihydrothiazol-2-yl)<lb/> amino]benzenesulfon-amide (8)<lb/></head>

			<p>Compound 2 (1.554 g, 6.5 mmol), and sulfanilamide (1.12 g,<lb/> 6.5 mmol) were dissolved in EtOH (150 ml) with a small amount of<lb/> piperidine. The mixture was refluxed for 6h, and then cooled down<lb/> at room temperature. The precipitated product was filtered off and<lb/> crystallized from MeOH to give compound 8. Orange crystals,<lb/> Yield 70% (1.71g), M.p: 168-170ºC. FT-IR spectrum ῡ (cm -1 ):<lb/> 3180(NH), 3050(ArH), 2859(aliph. CH), 1690(C=O), 1592(C=C),<lb/> 1576(C=N), 1465, 1416(bend. CH 2 ), 1314 (NHSO 2 ), 1230(C-F),<lb/> 910, 826, 794(subst. phenyl), 706(C-F). 1 H NMR (400 MHz,<lb/> DMSO-d 6 ) δ (ppm): 8.2(s,1H, NH), 7.67, 7.66(Ar-CH=C), 7.65,<lb/> 7.63(d, d, 2H, CH-F), 7.46, 7.45(d,d, 2H, 2CH-SO 2 ), 7.40-7.34,<lb/> 6.89-6.58(each m, 4H , ArH), 2.50(NH 2 -SO 2 ). 13 C NMR (100 MHz,<lb/> DMSO-d 6 ) δ (ppm): 173(C=O), 169(Ar-CH=C), 162(C-F),<lb/> 152(C=N), 133.46-125.77(Ar carbons). Calculated, C 16 H 12<lb/> N 3 FS 2 O 3 (377), %: C, 50.92; H, 3.18; N, 11.14; F, 5.03; S, 16.97.<lb/> Found, %: C, 50.71; H, 3.01; N, 10.95; F, 4.89; S, 16.77.<lb/></p>

			<head>4.6. 4-Chloro-5-(4-fluorobenzylidene)thiazole-2(5H)-thione (9)<lb/></head>

			<p>A mixture of 2 (7 g, 29.28 mmol) and POCl 3 (15ml) was heated<lb/> to the fusion for 1h, and then cooled down at room temperature.<lb/> After that, it was poured onto ice and stirred. The precipitated prod-<lb/>uct was filtered off and crystallized from ethyl benzene to give<lb/> compound 9. Dark-green crystals, Yield 65% (4.91 g), M.p: 178-<lb/>180ºC. FT-IR spectrum ῡ (cm -1 ): 3060(ArH), 2854(aliph. CH),<lb/> 1594(C=N), 1229(C-F), 1192(C=S), 853, 827(subst. phenyl),<lb/> 707(C-Cl). 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 7.84 (Ar<lb/> CH=C), 7.78, 7.77(d,d, 2H, CH-F), 7.75-7.05(m , 2H, ArH). 13 C<lb/> NMR (100 MHz, DMSO-d 6 ) δ (ppm): 195(C=S), 169.4(Ar-CH=C),<lb/> 165(C-F), 162(C=N), 139.28(C-Cl), 133-122.33(Ar carbons). Cal-<lb/>culated, C 10 H 5 NFClS 2 (257), %: C, 46.69; H, 1.94; N, 5.44; F, 7.30;<lb/> S, 24.90; Cl, 13.61. Found, %: C, 46.48; H, 1.69; N, 5.33; F, 7.15;<lb/> Cl, 13.45; S, 24.79.<lb/></p>

			<head>4.7. 5-(4-Fluorobenzylidene)-4-[(4-fluorophenyl)amino] thia-<lb/>zole-2(5H)-thione (10)<lb/></head>

			<p>Equimolar amounts of compound 2 and p-fluoroaniline were<lb/> dissolved in DMF (15 ml) and refluxed for 1h. The mixture was<lb/> then cooled down at room temperature and poured onto ice. The<lb/> precipitated product was filtered off and crystallized from ethanol<lb/> to give compound 10. Dark-brown crystals, Yield 82% (1.73 g),<lb/> M.p: 179-180ºC. FT-IR spectrum ῡ (cm -1 ): 3151(NH), 3060(ArH),<lb/> 2880 (aliph. CH), 1603(C=C), 1574(C=N), 1221(C-F), 830,<lb/> 810(subst. phenyl), 710 (C-F). 1 H NMR (400 MHz, DMSO-d 6 ) δ<lb/> (ppm): 8.26 (s, 1H, NH), 7.7(Ar-CH= C), 7.698, 7.694(d, d, 2H,<lb/> CH-F), 7.68, 7.63(d,d, 2H, CH-F ), 7.61-7.45, 7.37-7.12(each m,<lb/> 4H, ArH). 13 C NMR (100 MHz, DMSO-d 6 ) δ (ppm): 178.89(C=S),<lb/> 163.07(Ar-CH=C), 159.46(C-F), 157.53(C-F), 155(C=N), 135.65-<lb/>126.25(Ar carbons). Mass spectrum, m/z (I rel , %): 332(335, M+3,<lb/> 1.18%); 164(25.10), 110(85.0), 109(80.11), 95(100), 71(12.0),<lb/> 58(15.1). Calculated, C 16 H 10 N 2 F 2 S 2 (332), %: C, 57.83; H, 3.02; N,<lb/> 8.43; F, 11.44; S, 19.27. Found, %: C, 57.61; H, 2.85; N, 8.12; F,<lb/> 11.08; S,19.11.<lb/></p>

			<head>4.8. 3-(4-Fluorophenyl)-3,6-dihydro-5H-pyrazolo[3,4-d] thia-<lb/>zole-5-thione (11)<lb/></head>

			<p>A solution of compound 2 (1.635 g, 6.34 mmol) and NH 2 NH 2<lb/> (0.2 g, 6.34 mmol) was dissolved in DMF (50ml) and refluxed for 6<lb/> h. The reaction mixture was cooled down at room temperature, and<lb/> then poured onto ice. The precipitated product was filtered off and<lb/> crystallized from EtOH to give compound 11. Light-brown crystals,<lb/> Yield 72% (1.24 g), M.p: 133-135ºC. FT-IR spectrum ῡ (cm -1 ):<lb/> 3180(NH), 3060(ArH), 2880(aliph. CH), 1644(bend. NH),<lb/> 1607(C=C), 1568(C=N), 1230(C-F), 1150(C=S), 862, 810(subst.<lb/> phenyl), 716(C-F). 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 8.5(s,<lb/> 1H, NH), 7.8(Ar CH=C), 7.3, 7.2(d,d, 2H, CH-F), 7.0-6.5(m, 2H,<lb/> ArH). 13 C NMR (100 MHz, DMSO-d 6 ) δ (ppm): 180(C=S), 147(C-<lb/>F), 142(C=N), 138(C=C), 133-123(Ar carbons). Calculated,<lb/> C 10 H 7 N 3 FS 2 (252), %: C, 47.61; H, 2.77; N, 16.66; F, 7.53; S,<lb/> 25.39. Found, %: C, 47.42; H, 2.55; N, 16.41; F, 7.11; S, 25.09.<lb/></p>

			<head>4.9. 2-(4-Chlorophenyl)-3-(4-fluorophenyl)-1,2-dihydro-5H-pyr-<lb/>azolo[3,4-d]thiazole-5-thione (12)<lb/></head>

			<p>Compound 2 (1.635 g, 6.34 mmol) and 4-chlorophenyl hydra-<lb/>zine HCl (0.904 g, 6.34 mmol) were dissolved in DMF (50ml) and<lb/> refluxed for 6h. The mixture was then cooled down at room tem-<lb/>perature and onto ice. The precipitated product was filtered off and<lb/> crystallized from ethanol to give 12. Black crystals, Yield 78%<lb/> (1.93g), M.p: 188-190ºC. FT-IR spectrum ῡ (cm -1 ): 3239(NH),<lb/> 3060(ArH), 2900(aliph. CH), 1596(C=C), 1567 (C=N), 1488(bend.<lb/> CH), 1225(C-F), 1157(C=S), 890, 823, 786(subst. phenyl), 736(C-<lb/>F), 664(C-Cl). 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 10.47(s,<lb/> 1H, NH), 7.87, 7.71(d,d, 2H, CH-F), 7.0, 7.69 (d,d, 2H, CH-Cl),<lb/> 7.63-7.24 &amp; 7.23-6.72(each m, 4H , ArH). 13 C NMR (100 MHz,<lb/> DMSO-d 6 ) δ (ppm): 179.38(C=S), 168(C-S), 160(C=N), 148(C-F),<lb/> 144(C-N), 137(C-C), 132.95-121.37(Ar carbons). Calculated, C 16<lb/> H 9 N 3 FCl S 2 (361), %: C, 53.18; H, 2.49; N, 11.63; F, 5.26; Cl, 9.27;<lb/> S, 17.72. Found, %: C, 52.98; H, 2.39; N, 11.51; F, 5.20; Cl, 8.89;<lb/> S, 17.55.<lb/></p>

			<head>4.10.<lb/> 2-[(5-(4-Fluorobenzylidene)-4-oxo-4,5-dihydrothiazol-2-<lb/>yl)thio]acetic acid (13)<lb/> </head>
				
			<p>Compound 2 (4 g, 16.73 mmol) and chloroacetic acid (1.58 g,<lb/> 16.73 mmol) were dissolved in DMF (25 ml) and refluxed for 1h.<lb/> The reaction mixture was then cooled down at room temperature<lb/> poured onto ice. The precipitated product was filtered off and crys-<lb/>tallized from ethanol to give compound 13. Light-yellow crystals,<lb/> Yield 65% (3.23 g), M.p: 238-240ºC. FT-IR spectrum ῡ (cm -1 ):<lb/> 3500-3100(broad, OH), 3060(ArH), 2937, 2880(aliph. CH), 1693,<lb/> 1675(2C=O), 1595(C=C), 1562 (C=N), 1443, 1411(bend. CH 2 ),<lb/> 1232(C-F), 1001(C-S-C), 827, 793(subst. phenyl), 749 (C-F). 1 H<lb/> NMR (400 MHz, DMSO-d 6 ) δ (ppm): 7.0(Ar CH=C), 7.697,<lb/> 7.690(d,d, 2H, CH-F), 7.630-7.360(m, 2H, ArH ), 2.50(2H, CH 2 ).<lb/> 13 C NMR (100 MHz, DMSO-d 6 ) δ (ppm): 178.91(C-S), 163.0(Ar-<lb/>CH=C), 161(C-F), 144(C=N), 131.84-128.59(Ar carbons),<lb/> 49.56(CH 2 carbons). Calculated, C 16 H 8 NFS 2 O 3 (297), %: C, 48.48;<lb/> H, 2.69; N, 4.71; F, 6.39; S, 21.54. Found, %: C, 48.31; H, 2.43; N,<lb/> 4.55; F, 6.12; S, 21.40.<lb/></p>

			<head>4.11. 5-(4-Fluorobenzylidene)-2-(methylthio)thiazol-4(5H)-one<lb/> (14)<lb/></head>

			<p>Compound 13 (1.5 g, mmol) and aq. K 2 CO 3 (5%, 15 ml) were<lb/> heated for 1h, and then cooled down followed by neutralization by<lb/> AcOH to give 14. Light-yellow crystals, Yield 55% (0.70g), M.p:<lb/> 173-175ºC. FT-IR spectrum ῡ (cm -1 ): 3050(ArH), 2936(aliph. CH),<lb/> 1674.9(C=O), 1620(C=C), 1599(C=N), 1467, 1411(bend. CH 3 ),<lb/> 1224(C-F), 1050(C-S-C), 853, 832, 822(subst. phenyl), 723(C-F).<lb/> 1 H NMR (400 MHz, DMSO-d 6 ) δ (ppm): 7.70(Ar CH=C), 7.69,<lb/> 7.68(d,d, 2H, CH-F), 7.63-7.53, 7.37-7.16(2H , ArH), 2.51 (Me-S).<lb/> 13 C NMR (100 MHz, DMSO-d 6 ) δ (ppm): 184, 179(C-S), 163.52<lb/> (Ar-CH=C), 162.70(C-F), 161.55(C=N), 136-121.39(Ar CH),<lb/> 26.21(CH 3 ). Calculated, C 11 H 8 NFS 2 O (253), %: C, 52.17; H, 3.16;<lb/> N, 5.53; F, 7.50; S, 25.29. Found, %: C, 52.01; H, 2.89; N, 5.28; F,<lb/> 7.31; S, 25.11.<lb/></p>

			<head>4.12. 2,2&apos;-(Piperazine-1,4-diyl)bis[5-(4-fluorobenzylidene) thia-<lb/>zol-4(5H)-one] (15)<lb/></head>

			<p>Compound 2 (4 g, 16.73 mmol) and piperazine (0.721 g, 8.37<lb/> mmol) were dissolved in EtOH (70 ml), refluxed for 6-8h, and then<lb/> cooled down. The precipitated product was filtered off and crystal-<lb/>lized from ethanol to give compound 15. Yellow crystals, Yield<lb/> 85% (3.53g), M.p: 273-275ºC. FT-IR spectrum ῡ (cm -1 ):<lb/> 3060(ArH), 2939, 2880(aliph. CH), 1690, 1666(2C=O),<lb/> 1597(C=C), 1564 (C=N), 1505, 1414(bend. CH 2 ), 1231(C-F), 847,<lb/> 826, 810(subst. phenyl), 725(C-F). 1 H NMR (400 MHz, DMSO-d 6 )<lb/> δ (ppm): 7.70(Ar-CH=C), 7.696, 7.693, 7.68, 7.65(each d,d , 4H ,<lb/> CH-F), 7.54-7.36 , 7.35-7.17(each m, 4H , ArH), 2.90, 2.89 ,2.86 ,<lb/> 2.55, 2.51(4 CH 2 ). 13 C NMR (100 MHz, DMSO-d 6 ) δ (ppm):<lb/> 173.74, 173.2(C=O), 163.11, 161.90(C-F), 131.86-115.95(Ar car-<lb/>bons), 49.91-49.18(CH 2 ). Calculated, C 24 H 18 N 4 F 2 S 2 O 2 (496), %: C,<lb/> 58.06; H, 3.62; N, 10.88; F, 7.66; S, 12.90. Found, %: C, 57.85; H,<lb/> 3.41; N, 10.44; F, 7.49; S, 12.78.<lb/></p>

			<head>4.13.<lb/> 1,4-Bis(3-(4-fluorophenyl)-3H-pyrazolo[3,4-d]thiazol-5-<lb/>yl)piperazine (16)<lb/> </head>
				
			<p>Compound 15 (2.5 g, 5.03 mmol) and hydrazine hydrate (0.503<lb/> g, 10.06 mmol) were dissolved in EtOH (45 ml) with a small<lb/> amount of piperidine, and refluxed for 6-8h. The reaction mixture<lb/> was cooled down at room temperature, and then poured onto ice.<lb/> The obtained product was filtered off and crystallized from MeOH<lb/> to give compound 16. Orange crystals, Yield 70% (1.835g), M.p:<lb/> 188-190ºC. FT-IR spectrum ῡ (cm -1 ): 3080(ArH), 2938,<lb/> 2880(aliph. CH), 1600(C=C), 1560(C=N), 1221(C-F), 914, 821,<lb/> 785 (substituted-phenyl), 742(C-F). 1 H NMR (400 MHz, DMSO-<lb/>d 6 ) δ (ppm): 10.27(s, 1H, C 5 -H of thiazole), 7.8-7.76, 7.40-7.34<lb/> (each d,d, 4H, CH-F), 7.31-6.86(m, 4H, ArH). 13 C NMR (100 MHz,<lb/> DMSO-d 6 ) δ (ppm): 172.21(S-CN-N), 161(C-F), 132.8-114.93 (Ar<lb/> carbons), 47-46.9(CH 2 ), 24.6-23.76(CH). Mass spectrum, m/z (I rel ,<lb/> %): 520(524, M+3, 15.15%), 218(5.16), 124(27.0), 190(8.5),<lb/> 95(100), 96(12.1), 85(70.0). Calculated, C 24 H 18 N 8 F 2 S 2 (520), %: C,<lb/> 55.38; H, 3.46; N, 21.53; F, 7.30; S, 12.30. Found, %: C, 55.18; H,<lb/> 3.28; N, 21.11; F, 7.15; S, 12.20.<lb/></p>

			<head>CONCLUSION<lb/></head>

			<p>Due to the high resistance of fungi towardantibiotics and drugs,<lb/> the present work designed, synthesized and evaluated them as dual<lb/> binding site modified fluorine compounds bearing rhodanine drug<lb/> inhibitors<lb/> </p>
				
			<p>Thus, in search for new rhodanine derivatives, the recent devel-<lb/>opment of rhodanine via the introduction of both fluorine atoms<lb/> followed by alkyl, amino and hydrazino substituents at C-2, N-3,<lb/> C=O and CH 2 corresponding to 2, 3, 4 and 5-position has been de-<lb/>duced with a hope to obtain highly biologically active probes for<lb/> their enzymatic effects on the cellobiase activity produced by some<lb/> fungi and as CDK2 inhibitors of tumor cells.<lb/></p>

			<p>The importance of novel fluorine substituted rhodanine as<lb/> modified drugs has been highlighted in this study. The highly bio-<lb/>active substitutes at positions 2 and 5 have gainedmore attention of<lb/> the researchers. The study also concluded that both the compounds<lb/> 2 and 10 can be used as Olomoucine (standard referees).</p>


	</text>
</tei>